Search for: "Novartis Pharmaceuticals Inc"
Results 261 - 280
of 395
Sort by Relevance
|
Sort by Date
15 Jun 2010, 3:00 am
One such company, Novartis Pharmaceuticals Canada Inc., sold the Exelon patch, which essentially is a transdermal patch which is used to treat mild to moderate symptoms of dementia. [read post]
2 Jun 2010, 8:50 am
Department of Energy 82 Teach for America 83 Abbott 84 AT&T 85 MGM Mirage 86 Mayo Clinic 87 Lockheed Martin Corporation 88 Merck 89 Limited Brands 90 Hyatt Hotels and Resorts 91 Colgate-Palmolive Company 92 Dell Inc. 93 Lilly 94 Novartis Pharmaceuticals Corporation 95 The Vanguard Group 96 Oracle 97 Vestas 98 Wal-Mart Stores Inc. 99 Honda Companies 100 [read post]
27 May 2010, 3:40 pm
Merrell Dow Pharmaceuticals, Inc., 791 F. [read post]
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
17 May 2010, 7:10 pm
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals will pay $72.5 million to settle civil False Claims Act allegations that the company caused false claims to be submitted to federal health care programs through its marketing of the drug TOBI. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
13 May 2010, 12:27 pm
Novartis Pharmaceuticals Corp., 642 F. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
4 May 2010, 10:29 pm
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote Innovation files false… [read post]
8 Apr 2010, 9:48 am
Roche Laboratories, Inc., 243 F. [read post]
1 Apr 2010, 1:42 pm
Novartis Pharmaceuticals Corp., 2000 WL 33915848 (E.D. [read post]
22 Mar 2010, 4:13 am
Novartis Pharmaceuticals Corp., 564 F. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
4 Mar 2010, 3:28 pm
., and Novartis Pharmaceuticals, Inc.). [read post]
26 Feb 2010, 4:17 pm
Novartis Pharmaceuticals Corp.; Simonian v. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
